Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1090 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Valeant Pharma to buy Ortho Dermatologics

Valeant will pay Janssen $345m for prescription brands like RETIN-A MICRO, ERTACZO and RENOVA. Valeant Pharmaceutical chairman and CEO Michael Pearson said with the combination of this transaction

EMD Serono designates new president

He will also serve as a member of executive management board for Merck Serono. Previosly, he worked as a chief commercial officer for EMD Serono and was responsible

Vical, Astellas Pharma sign licensing deals

Under the contracts, Astellas will develop and commercialize TransVax, however Vical will take care of the co-promotion in US. Additionally, Vical will support Astellas in manufacturing, development and

BioMarin starts Phase 1 BMN 673 trial

The open-label, two-arm dose escalation trial intends to establish the maximum tolerated dose of BMN 673. The trial will also evaluate the pharmacodynamics, pharmacokinetics, safety and preliminary efficacy